Inactive Instrument

PIRML ENT

Stocks

Published on 05/06/2025 - Modified on 05/30/2025 at 10:51 pm IST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Ladies and gentlemen, good day and welcome to the Q4 FY 2025 earnings conference call of Piramal Enterprises Limited. [Operator Instructions]

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

23/01	Piramal Enterprises Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
30/25/30	Piramal Pharma Solutions Formalizes Partnership with IntoCell, Expanding Its Payload-Linker Platform and Bioconjugate Capabilities	CI
20/25/20	Jefferies Adjusts Piramal Enterprises' Price Target to INR1,015 From INR1,000, Keeps at Underperform	MT
17/25/17	Piramal Enterprises Limited, Q2 2026 Earnings Call, Oct 17, 2025
19/25/19	Piramal Enterprises Limited Announces Resignation of Upma Goel as Key Managerial Personnel, with Effect from September 30, 2025	CI
19/25/19	Piramal Enterprises Limited Announces Resignation of Upma Goel as Chief Financial Officer, with Effect from September 30, 2025	CI
10/25/10	India New Issue-Piramal Finance to issue near 3-year bonds, bankers say	RE
30/25/30	Jefferies Adjusts Piramal Enterprises' Price Target to INR1,000 From INR835, Keeps at Underperform	MT
29/25/29	Piramal Enterprises Limited, Q1 2026 Earnings Call, Jul 29, 2025
29/25/29	Piramal Enterprises Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
29/25/29	Piramal Enterprises' CFO Resigns; Vikash Singhla to Take Over Post-Merger	MT
29/25/29	Piramal Enterprises June-quarter consol profit 2.76 billion rupees	RE
21/25/21	Piramal Enterprises to consider fund raising	RE
30/25/30	Piramal Enterprises Limited Approves Final Dividend for the Financial Year Ended March 31, 2025	CI
06/25/06	Piramal Enterprises Gets Board Nod to Raise INR2.4 Billion Through Debenture Allotment	MT

Duration

Period

Sector

BBB